EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials

Tim Mori iD, Sho Komukai, Satoshi Hattori, Tim Friede iD

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.2459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Tim Mori und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Ger…. Hauptthemen laut MEDLINE: Models, Statistical, Research Design, Clinical Trials as Topic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In event‐driven trials, the target power under a certain treatment effect is maintained as long as the required number of events is obtained. The misspecification of the survival function in the planning phase does not result in a loss of power. However, the trial might take longer than planned if the event rate is lower than assumed. Blinded sample size reestimation (BSSR) uses non‐comparative interim data to adjust the sample size if some planning assumptions are wrong. In the setting of an event‐driven trial, the sample size may be adjusted to maintain the chances to obtain the required number of events within the planned time frame. For the purpose of BSSR, the survival function is estimated based on the interim data and often needs to be extrapolated. The current practice is to fit standard parametric models, which may however not always be suitable. Here we propose a flexible spline‐based BSSR method. Specifically, we propose to carry out the extrapolation based on the Royston–Parmar spline model. To compare the proposed procedure with parametric approaches, we carried out a simulation study. Although parametric approaches might seriously over‐ or underestimate the expected number of events, the proposed flexible approach avoided such undesirable behavior. This is also observed in an application to a secondary progressive multiple sclerosis trial. Overall, if planning assumptions are wrong this more robust flexible BSSR method could help event‐driven designs to more accurately adjust recruitment numbers and to finish on time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, StatisticalResearch DesignClinical Trials as TopicSample SizeHumansComputer SimulationData Interpretation, Statistical

Stichwörter der Autor:innen

Royston–Parmar modelblinded sample size reestimationevent‐driven designssplinessurvival extrapolation

Autor:innen und Institutionen

  • Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
  • German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Department of Biomedical Statistics, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan.
  • DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, Göttingen, Germany.

ORCID-Profile: Tim Mori, Tim Friede

Zitieren

APA

Mori, T., Komukai, S., Hattori, S., & Friede, T. (2025). Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2459

Vancouver

Mori T, Komukai S, Hattori S, Friede T. Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2459

BibTeX
@article{Mori2025,
  author = {Mori, Tim and Komukai, Sho and Hattori, Satoshi and Friede, Tim},
  title = {Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.2459}
}
Kostenlos starten →